Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Question yourself, why does management go to stock options at this point. Because they know the return potential for such stock options is better than cash they can pay management. Secondly, management isn't turning to options if they feel like they are going to fail here. Two big deals in the works for sale of diet drug and they don't even have to do the fieldwork for it, Canadien and a European company's will be doing it for them. Just manufacture and dispense so to speak.
The diet drug is going to hit the European markets this quarter and the Canadien markets the first or second quarter of 2017. This stock is about to rebound.
If it hits $1.00 then so be it, I will still be retiring 22 years ahead of schedule.
They have presented in PRs, conference calls, and interviews; that they have had to delay taking on facilities seeking their services and that they were waiting for them to obtain the robot so that they could take on the additional demand for services. I hope that is the case still. Also, I am sure they are in the process of establishing these same services in licensed states, so any increases the current processes and robot can handle.
They already have the 2 million to work with for acquisitions.
The train is making an extended stop at Fort Knox on its way. Love this solid stock/company.
Management was pretty clear with today's PR on exactly what this installation means for the business line. You know with any equipment purchase you do a Return On Investment calculation to see how it is actually going to help the bottom line. Ms. MARS is announcing expectations for the quarters to come and those thereafter. RXMD management is on a path to increased revenues and profitability. It's the side-effect of purchases like these, fortunately for those of us invested here.
It looked like 400k or better got put on ask at .035 and then patience got the better of them and they dumped it into the .0311 and .0310 bids. That's less we have to pick through later, so I thank the seller in more ways than one
Still waiting on confirmation of the robot up and running with completion of that first days worth of scripts.
That CELLEBRATION was a two fold pund. Cells and calibration.
Had not seen this article yet, but made some good points regarding past, present, and future of RXMD
http://oracledispatch.com/2016/09/18/progressive-care-inc-otcmktsrxmd-stock-buzz/
Good info on progress. Thanks for sharing. The machine looks like it wouldn't take too long to set up, most of the man hours will be in entering drugs into machine, calibrating the 225 trays/cells for dispensing meds, followed by a series of validation testing. Really looking forward to a successful implementation.
To some it may not seem like much, but for RXMD it allows them to finally be able to accept the business from the health facilities that have been waiting patiently for them to get this in place so they can handle about 40-50% more business. More revenues with minimal costs leaves the opportunity for better profit margins. Big deal!! Go RXMD
People must be smartening up though the ask is thinning.
I got my eyes set on that 163k shares on the ask.
This is one of a kind. I have never seen a penny stock so public either. Think about all the conferences they have been to, all the investor and company interviews. Management is just so open and honest. Things overall look great here. Glad to have found this one. Even if I wouldn't have found this earlier i would still be taking a starting position here. My confidence is so high here that I didn't even hesitate to average up when I bought 600k shares at .047 back in June. I know this is just merely a resting point for this stock. My stock broker for my TD Ameritrade Institutional account is well aware of this stock, so if it does start to take off, word of mouth will help.
You know you guys are all right. This company is in beginning stages here. Although the steps they have made this year have been the most aggressive to date in terms of moving this company to the next level. Why those havent been realized yet by potential investors is beyond me.
Just a couple points:
1. Robot capable of filling over 1000 scripts a day which will allow for increased sales/revenues.
2. Pharmacy license expansion to other states.
3. Financials being reviewed on a quarterly basis with a very likely end of year audit of financials.
4. Merger and acquisitions actively being sought.
Welcome to RXMD, you obviously seen what all of us here see in this penny stock. Like you said a 100% legitimate business with sales, revenues, profits, ambitious management, uplisting plans, soon to be audited Financials, and expansion and acquisition initiatives in play. This investment is solid. It may take it turns here and there, but longterm its set to be great one for all of us.
I hope, but i bet the hurricane either sped up or slowed down the process. Hopefully they have it online by at latest mid-November. Start accepting new customers/organizations. Nov/Dec and ramp up operations for CY 2017
A poster questioned me regarding profit margin percentages today. When we start seeing improvements in this area the pps will reflect that as well. Increase revenues here and be lean on the costs/expenses needs to be another focus of management.
For those of you who have any question in your head regarding the direction of this company. Just do some research on the ScriptPro CRS 225 Robot. They aren't just playing around, largest one available of this model.
Do you see a straight line up here in these scripts numbers or revenues for that matter. We don't know what happened in August, could have been a first time large fill for a customer for one of our specialty medicines or compounds, that may not need to be filled again 3 to 4 months from now. Who knows.
Where you can see a straight line up is from this years to prior year numbers, every single month.
Orange are estimates based on FY 2016 YTD Averages
Since when is September the first month in the quarter?
And editing your message afterwards doesn't mean that you still don't have your wires crossed. We know nothing about what caused the spike to 20,000 scripts in August, it could have been a large first time order for one of our specialty medicines or compounds. That won't be required to be filled again for 3 months. Who knows. But I know the trend shows us going up.
Like i said some poster's wires have been crossed this morning. Statements made that dont even jive with how they release numbers. Lets put this in perspective for all. Scripts for September 2015 were 17,000 and net revenues were $1.1 million compared to 19,000 and $1.6 million, respectively. That's how this company reports because they know month to month in the same year is inefficient due to fluctuations in refill schedules.
The month over month increases they boast about have almost always been month over month compared to prior year. Your wires are crossed this morning, because both increased as usual. No fluff here.
Truth of the matter is we should expect scripts to somewhat level out until we get robot online, as they noted customers were waiting in line for us to accept their business once we got the robot online to increase our capacity.
Whats important is that Net revenue gains were proportional. 47% for August and 45% for September. The scripts will fluctuate based on higher fill months and refill schedules. Aka. 30, 60, 90 day. A lot of refills in the HC industry are on 90 day schedules.
Good numbers, as usual. Tallying back to last October, that makes 206K scripts filled and $17.2 million in Net Revenues compared to the 170K scripts and $12.8 million net revenues for the same time period from a year before. Additiknally, Remember production has been limited until we can get robot up and running for increased fills too.
Good close today although extremely immaterial to this stock in terms of actual $value$
Yah here i am scrounging for ways to find more money to put into this, and we have people putting shares lower on the ask. Makes me realize some sellers have no clue about this stock and where it is headed both short term and long term.
Regardless of the heavily undervalued price, I am excited to see the news for this week. Most likely Thursday since none today. I love seeing the gradual progression of scripts and revs throughout the year, and that is wo Pharmco truly tapping into the out of state markets yet with their new licenses. Greatness to come yet.
RXMD is a strong pinkie, and pinkie days are about to see their end. Cheers to NASDAQ uplist.
You as well as me know where this is heading, so of course the patience is paying off and going to pay off even more over the next year. Looking forward to management achieving their goal of uplisting.
Based on actual and estimated Sept. We will be at 13.4 million revenue through first 9 months in 2016 which will be about a 36% improvement over prior year 3 quarters which was about 9.8 million revenue.
A few other holes in that article too. Keep referring to 2015 numbers for this years 9 month period. We don't even know this years nine month results.
Lol. I laughed at both those comments. RXMD finally seeing the move up it has earned.
September script and revenue numbers around the corner. In addition to quarterly conference call. September had the highest number of scripts last year of any month. Lets see if it holds true this year.
There's pressure alright. But the sellers are falling fast.
Nice work big guy. I was going to post projections, but u knocked it out of the park w this post, and that was even before RXMD blew the walls off of the building (literally and physically) with their outstanding August revenues. Company is obviously already taking advantage of those out of state licenses. I posted awhile back how this could expand scripts and sales with just minor increases % increases in out-of-state sales. RXMD is on their way up and reach is expanding beyond Miami Dade.
RXMD is about transparency and facts. Everything you need to know has been laid out in the Quarterlies, and has been verified as fact to the best of their knowledge as evidenced by the FULL CERTIFICAES signed by Administration in the 2nd half of the quarterly information. Those are there for a reason. What other pinky have you seen those on?
Some items posted you can trust, but you can't always believe what you read on these message boards. You will have to do your own digging on certain items.
Beautiful response.
Go RXMD